Cardiac Guidance vs Reveal LINQ

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Cardiac Guidance

by Caption Health

Reveal LINQ

by Medtronic

AI Verdict

Tool A, Caption Health's Cardiac Guidance, is an AI-powered software accessory for real-time cardiac ultrasound image acquisition and interpretation at the point of care, focusing on structural and functional assessments. In contrast, Medtronic's Reveal LINQ is an implantable cardiac monitor that continuously records ECG for long-term detection and diagnosis of cardiac arrhythmias using AI algorithms. While both utilize AI in cardiology, they address different diagnostic needs: one for immediate imaging and the other for prolonged rhythm surveillance.

Choose Cardiac Guidance if…

Choose Cardiac Guidance if you need to empower healthcare professionals, including those without extensive ultrasound expertise, to perform diagnostic-quality cardiac ultrasound assessments at the point of care. This tool is ideal for scenarios requiring immediate cardiac imaging, such as in emergency medicine or primary care, to facilitate early disease detection and improve access to critical cardiac evaluations.

View Cardiac Guidance →

Choose Reveal LINQ if…

Choose Reveal LINQ if your patient requires long-term, continuous cardiac rhythm monitoring to detect infrequent or asymptomatic arrhythmias over an extended period, up to three years. This implantable device is best suited for diagnosing conditions like cryptogenic stroke, unexplained syncope, or paroxysmal atrial fibrillation that may be missed by shorter-term monitoring methods.

View Reveal LINQ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Cardiac Guidance	Reveal LINQ
Deployment	Caption Guidance is deployed in acute point-of-care settings, including emergency and anesthesiology departments and critical care units. It is also used in doctors' offices and can be used for at-home care.	The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs.
FDA Status	Cleared AI-estimated	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardiac Guidance

Tool A (Cardiac Guidance) is specifically designed to enable non-expert ultrasound users to acquire diagnostic-quality cardiac images through real-time AI guidance and on-screen instructions. This significantly lowers the barrier to performing complex echocardiograms, making it highly user-friendly for a broader range of healthcare professionals.

Clinical Value

Reveal LINQ

Tool B (Reveal LINQ) offers continuous ECG monitoring for up to three years, utilizing AI algorithms to accurately detect and diagnose intermittent cardiac arrhythmias that might otherwise be missed. This long-term, discreet monitoring provides crucial diagnostic information for conditions like atrial fibrillation and unexplained syncope, leading to more definitive diagnoses and potentially improved patient outcomes.

Pricing & Value

Reveal LINQ

While both tools have opaque pricing, Medtronic's Reveal LINQ has more readily available information on its cost-effectiveness and established reimbursement pathways, particularly for specific indications like cryptogenic stroke and unexplained syncope. Studies highlight its value in reducing stroke recurrence and improving quality-adjusted life years, providing a clearer value proposition for healthcare systems.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness. Tool A (Cardiac Guidance) is FDA-cleared, HIPAA compliant, explicitly states BAA availability, and integrates with compatible general-purpose diagnostic ultrasound systems. Tool B (Reveal LINQ) is also FDA-cleared and HIPAA compliant, and benefits from Medtronic's extensive experience as a global medical device leader with a mature ecosystem for deployment and data management.

Innovation

Cardiac Guidance

Tool A (Cardiac Guidance) stands out for its innovation in democratizing a complex diagnostic skill. Its real-time AI guidance, turn-by-turn probe instructions, and automated quality assessment enable non-expert users to acquire diagnostic-quality cardiac ultrasound images, significantly expanding access to critical cardiac assessments at the point of care.

Support & Docs

Reveal LINQ

Tool B (Reveal LINQ) benefits from Medtronic's extensive resources as a large, established global medical device company. It offers a comprehensive support infrastructure, including dedicated patient and technical services, detailed manuals, patient education materials, and a global presence, which generally surpasses that of a smaller, albeit innovative, company.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Cardiac Guidance	Reveal LINQ
Primary Function	AI tool that empowers healthcare professionals to acquire and interpret diagnostic-quality cardiac ultrasound images at the point of care, democratizing access to critical cardiac assessments.	Tiny, implantable cardiac monitor that continuously records ECG for up to three years, utilizing AccuRhythmu2122 AI algorithms to accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope.
Key AI Capabilities	Real-time AI guidance for cardiac ultrasound image acquisition, automated quality assessment with a 'Quality Meter', auto-capture of diagnostic-quality images and video clips, automated left ventricular ejection fraction (EF) calculation (Caption Interpretation).	AccuRhythmu2122 AI algorithms to accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope, with reduced false alerts (AF and pause).
Target Users/Environment	Healthcare professionals, non-expert ultrasound users, at the point of care.	Patients (implantable device), clinicians (mobile app for device management), via CareLinku2122 network.
Monitoring/Assessment Scope	Real-time AI guidance and interpretation for 10 standard echocardiographic views.	Continuous ECG monitoring for up to three years.
Categories	Cardiology AI, Radiology & Imaging AI	Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties	Cardiology, Emergency Medicine, Radiology	Cardiology, Neurology

Videos

Demos, reviews, and walkthroughs featuring Cardiac Guidance and Reveal LINQ.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical application difference between Cardiac Guidance and Reveal LINQ?

Cardiac Guidance is an FDA-cleared AI tool designed to help healthcare professionals acquire and interpret diagnostic-quality cardiac ultrasound images at the point of care, aiming to democratize access to critical cardiac assessments. Reveal LINQ is a tiny, implantable cardiac monitor that continuously records ECG for up to three years, utilizing AI algorithms to accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope.

What specific cardiac conditions are each tool designed to address?

Cardiac Guidance focuses on enabling diagnostic-quality cardiac assessments through ultrasound imaging, supporting early disease detection. Reveal LINQ is designed to detect and diagnose cardiac arrhythmias, such as atrial fibrillation, cryptogenic stroke, and unexplained syncope, through continuous ECG monitoring.

What is the role of AI in each of these tools?

In Cardiac Guidance, AI provides real-time guidance for cardiac ultrasound image acquisition, turn-by-turn on-screen probe movement instructions, automated quality assessment, auto-capture of images, and automated left ventricular ejection fraction (EF) calculation. For Reveal LINQ, AccuRhythmu2122 AI algorithms are used to accurately detect and diagnose cardiac arrhythmias and reduce false alerts for conditions like bradycardia and pauses.

What kind of data output can a physician expect from each tool?

Cardiac Guidance provides diagnostic-quality cardiac ultrasound images and video clips, along with automated left ventricular ejection fraction (EF) calculations. Reveal LINQ continuously records ECG data for up to three years, offering automatic and patient-activated event recording related to cardiac arrhythmias.